| (Values in U.S. Thousands) | Jun, 2022 | Mar, 2022 | Dec, 2021 | Sep, 2021 | Jun, 2021 |
| Sales | 0 | 10 | 0 | 0 | 0 |
| Sales Growth | -100.00% | unch | unch | unch | unch |
| Net Income | -170 | -930 | -2,620 | -1,430 | -640 |
| Net Income Growth | +81.72% | +64.50% | -83.22% | -123.44% | +91.96% |
Global Wholehealth Partners Corp (GWHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Global WholeHealth Partners Corporation manufactures and markets various in vitro diagnostic test kits principally in the United States. The Company sells and develop in-vitro diagnostic products, including rapid diagnostic tests, such as the COVID-19 Test, rapid whole blood Ebola Test, whole blood Zika test, blood rapid TB test and other tests. Global WholeHealth Partners Corporation is based in San Clemente, California.
Fiscal Year End Date: 06/30